🔻Dr. William Makis just dropped his updated Ivermectin & Fenbendazole Cancer Protocol.
And people are losing their minds.

Not because it's controversial.

Because it gives real answers.

Here's the truth:
Most protocols treat every cancer the same.

Dr. Makis says that's a mistake.

A patient in remission ≠ a patient with widespread metastases.

A slow-growing tumor ≠ aggressive brain cancer.

So he designed FOUR dosing levels.
Not one. Four.

👇

🟢 LOW DOSE
Ivermectin: ≤ 0.5 mg/kg – 3x per week
Fenbendazole: 222 mg/day – 3 days on, 4 off

Best for: Remission support, prevention, strong family history, higher risk individuals.

🟡 MEDIUM DOSE
Ivermectin: 1.0 mg/kg – daily
Fenbendazole: 222 mg/day – 6 days per week

Best for: Most active cancers – common starting approach.

🔵 HIGH DOSE
Ivermectin: 2.0 mg/kg – daily
Fenbendazole: 444 mg/day – 6 days per week

Best for: Aggressive cancers, brain cancer, leukemia, pancreatic cancer.

🔴 VERY HIGH DOSE
Ivermectin: ≥ 2.5 mg/kg – daily
Fenbendazole: 888-1000 mg/day – 6 days per week

Best for: Extensive metastatic disease, poor prognosis cases.

💡 Why is this different?
It's not about the numbers.

It's about the thinking behind them.

Dr. Makis believes cancer isn't one disease. It's many.

And a one-size-fits-all approach?
That doesn't always make sense.

🔬 The research is growing.
Ivermectin and Fenbendazole are being studied for how they interact with:

• Cancer metabolism
• Cancer stem cells
• Mitochondrial function
• Tumor signaling pathways
• Treatment resistance mechanisms
• Cellular energy production

One thing is undeniable:
More cancer patients, caregivers, and researchers are talking about repurposed medicines today than ever before.

And that's exactly why charts like this keep getting shared.

📌 Save this chart.
Six months from now, you'll wish you knew where to find it.

🔁 Repost it. Someone researching cancer protocols needs to see this.

Share !

⟁

Subscribe @imPascalNajadi